Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells.
Where this comes from
- Record sourced from PubMed, PMID 41183007.
- Also identified by DOI 10.1371/journal.pone.0335701 and PMC identifier 12582416.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0065569.].